Wolfram Hoetzenecker (W Hoetzenecker)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Top Venues

Nature communications

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Julia Holzgruber, Christina Martins, Zsofi Kulcsar, Alexandra Duplaine, Erik Rasbach, Laure Migayron, Praveen Singh, Edith Statham, Jennifer Landsberg, Katia Boniface, Julien Seneschal, Wolfram Hoetzenecker, Emma L Berdan, Shannan Ho Sui, Matthew R Ramsey, Steven R Barthel, Tobias Schatton
Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade. Nature communications 15 (1) (2024)
Yun-Tsan Chang, Pacôme Prompsy, Susanne Kimeswenger, Yi-Chien Tsai, Desislava Ignatova, Olesya Pavlova, Christoph Iselin, Lars Einar French, Mitchell Paul Levesque, François Kuonen, Malgorzata Bobrowicz, Patrick M Brunner, Natalia Teresa Jarzebska, Wolfram Hoetzenecker, Emmanuella Guenova
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides. Nature communications 15 (1) (2024)
Yun-Tsan Chang, Pacôme Prompsy, Susanne Kimeswenger, Yi-Chien Tsai, Desislava Ignatova, Olesya Pavlova, Christoph Iselin, Lars Einar French, Mitchell Paul Levesque, François Kuonen, Malgorzata Bobrowicz, Patrick M Brunner, Natalia Teresa Jarzebska, Wolfram Hoetzenecker, Emmanuella Guenova
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides. Nature communications 15 (1) (2024)
Julia Holzgruber, Christina Martins, Zsofi Kulcsar, Alexandra Duplaine, Erik Rasbach, Laure Migayron, Praveen Singh, Edith Statham, Jennifer Landsberg, Katia Boniface, Julien Seneschal, Wolfram Hoetzenecker, Emma L Berdan, Shannan Ho Sui, Matthew R Ramsey, Steven R Barthel, Tobias Schatton
Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade. Nature communications 15 (1) (2024)
Julia Holzgruber, Christina Martins, Zsofi Kulcsar, Alexandra Duplaine, Erik Rasbach, Laure Migayron, Praveen Singh, Edith Statham, Jennifer Landsberg, Katia Boniface, Julien Seneschal, Wolfram Hoetzenecker, Emma L Berdan, Shannan Ho Sui, Matthew R Ramsey, Steven R Barthel, Tobias Schatton
Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade. Nature communications 15 (1) (2024)
Yun-Tsan Chang, Pacôme Prompsy, Susanne Kimeswenger, Yi-Chien Tsai, Desislava Ignatova, Olesya Pavlova, Christoph Iselin, Lars Einar French, Mitchell Paul Levesque, François Kuonen, Malgorzata Bobrowicz, Patrick M Brunner, Natalia Teresa Jarzebska, Wolfram Hoetzenecker, Emmanuella Guenova
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides. Nature communications 15 (1) (2024)
Yun-Tsan Chang, Pacôme Prompsy, Susanne Kimeswenger, Yi-Chien Tsai, Desislava Ignatova, Olesya Pavlova, Christoph Iselin, Lars Einar French, Mitchell Paul Levesque, François Kuonen, Malgorzata Bobrowicz, Patrick M Brunner, Natalia Teresa Jarzebska, Wolfram Hoetzenecker, Emmanuella Guenova
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides. Nature communications 15 (1) (2024)
Monika Ettinger, Teresa Burner, Anshu Sharma, Yun-Tsan Chang, Angelika Lackner, Pacôme Prompsy, Isabella M Deli, Judith Traxler, Gerald Wahl, Sabine Altrichter, Rupert Langer, Yi-Chien Tsai, Suraj R Varkhande, Leonie C Schoeftner, Christoph Iselin, Iris K Gratz, Susanne Kimeswenger, Emmanuella Guenova, Wolfram Hoetzenecker
Th17-associated cytokines IL-17 and IL-23 in inflamed skin of Darier disease patients as potential therapeutic targets. Nature communications 14 (1) (2023)
K Schumann, C Mauch, K C Klespe, C Loquai, U Nikfarjam, M Schlaak, L Akcetin, P Kölblinger, M Hoellwerth, M Meissner, G Mengi, A D Braun, M Mengoni, Reinhard Dummer, J Mangana, M A Sindrilaru, D Radmann, C Hafner, J Freund, K Rappersberger, F Weihsengruber, F Meiss, Lydia Reinhardt, F Meier, B Rainer, E Richtig, Julia Maria Ressler, C Höller, T Eigentler, Teresa Amaral, W K Peitsch, U Hillen, W Harth, F Ziller, K Schatton, T Gambichler, L Susok, L V Maul, H Läubli, D Debus, C Weishaupt, S Börger, K Sievers, S Haferkamp, V Zenderowski, V A Nguyen, M Wanner, R Gutzmer, P Terheyden, K Kähler, S Emmert, Alexander Thiem, M Sachse, S Gercken-Riedel, K M Kaune, K M Thoms, L Heinzerling, Markus Vincent Heppt, S Tratzmiller, Wolfram Hoetzenecker, A Öllinger, A Steiner, T Peinhaupt, M Podda, S Schmid, Uwe Wollina, T Biedermann, Christian Posch
Real world outcomes using PD-1 antibodies and BRAF+MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)